Pharma Industry News Novartis could cut its Kymriah price to $160,000 and keep its profit margins: study 8 years ago
Pharma Industry News Teva faces unexpected delay for its migraine drug candidate even as generics pressures worsen 8 years ago
Pharma Industry News Bad news for Novartis, good for GlaxoSmithKline: Sandoz’ Advair copy stiff-armed at FDA 8 years ago